Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Myasthenia Gravis

Interventions

DRUG

Subcutaneous immunoglobulins

Immunoglobulins used subcutaneously for maintenance of other immune mediated disorders.

Trial Locations (2)

George Washington University, Washington D.C.

Saint Louis University, St Louis